CD4 and melanoma: Studies on melanoma cells showed that IL-2 production increases the amount of interferon-γ-expressing CD8 T and natural killer cells in the tumor mass enhance Foxp3(+) CD4(+) regulatory T cells and anti-inflammatory cytokines such as IL-10, and also favor the expression of vascular cell adhesion molecule 1 on tumor vessels.